Revised SPCs: Cellcept (mycophenolate mofetil) preparations
SPC updated to note that mycophenolic acid has a cytostatic effect on B- and T-lymphocytes, therefore an increased severity of COVID-19 may occur. Dose reduction or discontinuation should be considered for patients in cases of clinically significant COVID-19.
Source:
electronic Medicines compendium